BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 53562)

  • 21. [The role of IgA and IgA antigliadin antibodies in the diagnosis and management of celiac disease].
    Torregrosa Sánchez R; Polo Martín P; Calabuig Sánchez M; Tomás Rates C; Vilar Escrigas P; Farre Massip C; Varea Calderón V; Alvarez Angel V; Sanchís-Bayarri Vaillant V
    An Esp Pediatr; 1989 Aug; 31(2):100-4. PubMed ID: 2696388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Class IgA antigliadin antibodies and monitoring of compliance to gluten-free diet in celiac disease].
    Volta U; Molinaro N; Fratangelo D; Bianco Bianchi F
    Ann Ital Med Int; 1990; 5(2):112-7. PubMed ID: 2248858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coeliac Disease: background and biochemical aspects.
    Hamer RJ
    Biotechnol Adv; 2005 Sep; 23(6):401-8. PubMed ID: 16006084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-specific cytotoxicity of wheat gliadin components towards cultured human cells.
    Hudson DA; Cornell HJ; Purdham DR; Rolles CJ
    Lancet; 1976 Feb; 1(7955):339-41. PubMed ID: 54743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention by mannan and other sugars of in vitro damage of rat fetal small intestine induced by cereal prolamin peptides toxic for human celiac intestine.
    Auricchio S; De Ritis G; De Vincenzi M; Latte F; Maiuri L; Pino A; Raia V; Silano V
    Pediatr Res; 1987 Dec; 22(6):703-7. PubMed ID: 3431955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The administration of gliadin downregulates the intraepithelial lymphocytosis induced by a rectal gluten challenge.
    Pedreira S; Dezi R; Niveloni S; Mauriño E; Bai JC; Goldin E; Ilan Y
    Am J Gastroenterol; 2003 Feb; 98(2):505-7. PubMed ID: 12591082
    [No Abstract]   [Full Text] [Related]  

  • 27. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease.
    Hischenhuber C; Crevel R; Jarry B; Mäki M; Moneret-Vautrin DA; Romano A; Troncone R; Ward R
    Aliment Pharmacol Ther; 2006 Mar; 23(5):559-75. PubMed ID: 16480395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Usefulness of the Alfa-Gliadin FAST, Gluten IgA EIA and gluten enteropathy test (GET) in the diagnosis and monitoring of the treatment of gluten intolerance in children].
    Waśniewska M; Domańska J; Kołakowska M; Siwińska-Gołebiowska H
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():62-4. PubMed ID: 1843812
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gluten-sensitive enteropathy--immune phenomena and pathogenetic concepts].
    Granditsch G
    Z Gastroenterol Verh; 1990 Apr; 25():55-7. PubMed ID: 1694364
    [No Abstract]   [Full Text] [Related]  

  • 30. Celiac disease.
    Polanco I
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S3-6. PubMed ID: 18667915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celiac disease.
    Cole SG; Kagnoff MF
    Annu Rev Nutr; 1985; 5():241-66. PubMed ID: 3896269
    [No Abstract]   [Full Text] [Related]  

  • 32. Celiac disease: from gluten to autoimmunity.
    Briani C; Samaroo D; Alaedini A
    Autoimmun Rev; 2008 Sep; 7(8):644-50. PubMed ID: 18589004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intolerance of gluten--a new disease or undiagnosed celiac disease].
    Sabel'nikova EA
    Eksp Klin Gastroenterol; 2012; (3):87-9. PubMed ID: 22830230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological evaluation of the alcohol-soluble protein fraction from gluten-free grains in relation to celiac disease.
    Bergamo P; Maurano F; Mazzarella G; Iaquinto G; Vocca I; Rivelli AR; De Falco E; Gianfrani C; Rossi M
    Mol Nutr Food Res; 2011 Aug; 55(8):1266-70. PubMed ID: 21710563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol.
    Valdés I; García E; Llorente M; Méndez E
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):465-74. PubMed ID: 12702901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological determination of gliadin 33-mer equivalent peptides in beers as a specific and practical analytical method to assess safety for celiac patients.
    Comino I; Real A; Moreno Mde L; Montes R; Cebolla A; Sousa C
    J Sci Food Agric; 2013 Mar; 93(4):933-43. PubMed ID: 22886585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a gliadin-containing gluten-free product in coeliac patients.
    Ciclitira PJ; Cerio R; Ellis HJ; Maxton D; Nelufer JM; Macartney JM
    Hum Nutr Clin Nutr; 1985 Jul; 39(4):303-8. PubMed ID: 3930437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the antigliadin antibody titer in adult celiac disease].
    Ferfoglia G; Fusco P; Sategna-Guidetti C
    Recenti Prog Med; 1989 May; 80(5):245-8. PubMed ID: 2762662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coeliac disease. Pathogenesis and clinical aspects.
    Friis SU
    APMIS Suppl; 1996; 61():1-48. PubMed ID: 8765057
    [No Abstract]   [Full Text] [Related]  

  • 40. Colostral IgA binding to wheat gluten and gliadin.
    Jonsson J; Schilling W; Forsberg M
    Clin Exp Immunol; 1982 Oct; 50(1):203-8. PubMed ID: 7172506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.